Skip to content
Search

Latest Stories

Welsh pharmacies receive funding boost for clinical services

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).


"This is fantastic news for patients, improving access to trusted, convenient care through their local community pharmacy. Community pharmacists already play a vital role in supporting their communities, and it’s encouraging to see that role increasingly recognised through investment in services such as STTT and the UTI,” said, Elen Jones, Royal Pharmaceutical Society director for Wales and England, said:

“Patient feedback on both services has been overwhelmingly positive. They not only provide care closer to home but also make the best use of pharmacists’ clinical expertise.”

Research has suggested that the treatments of STTT services in pharmacies has led to better use of antibiotics.

Research led by Dr. Efi Mantzourani found that 24 per cent of consultations through the Welsh pharmacy-led STTT service resulted in an antibiotic supply, compared to 39 per cent of GP consultations. For every 100 patients presenting with a sore throat at an STTT pharmacy, there was a reduction of approximately 15 to 18 antibiotic prescriptions.

Jones said this highlighted the critical role community pharmacy plays in the public health and called for that to reflected in improved funding for the sector.

"While this announcement is very welcome, it’s important to acknowledge that community pharmacy is under significant pressure,” she said.

“As we highlighted to politicians, together with CPW at the Senedd in 2024 and earlier this year following the results of our workforce wellbeing survey, pharmacy teams must be supported with adequate resources, protected time for training, and sustainable workloads to ensure these services can be delivered effectively and safely."

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less